Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
Faecal tumour necrosis factor-alpha in individuals with HIV-related diarrhoea.
AIDS. 1996 Aug;10(9):989-94. Unique Identifier : AIDSLINE MED/97006439 Sharpstone DR; Rowbottom AW; Nelson MR; Lepper MW; Gazzard BG; Department of HIV/Genitourinary Medicine, Chelsea and Westminster; Hospital, London, UK.
Abstract:
OBJECTIVE: HIV-related gastrointestinal infection is associated with diarrhoea, weight loss, mucosal inflammation and increased intestinal permeability. As tumour necrosis factor (TNF)-alpha may mediate these features this cytokine was measured in the faeces of HIV-seropositive individuals with diarrhoea to assess its role in the pathogenesis of HIV-related gastrointestinal disease and the association with specific intestinal pathogens. DESIGN: Prospective study. METHODS: Two hundred and four HIV-seropositive individuals provided stool samples that were analysed for faecal TNF-alpha (FTNF-alpha) using a standard sandwich enzyme-linked immunosorbent assay. RESULTS: Stool from patients with bacterial, cytomegalovirus (CMV) and microsporidial diarrhoea had significantly elevated FTNF-alpha compared with those who had pathogen-negative diarrhoea (P < 0.05). FTNF-alpha was not raised in cryptosporidiosis, pathogen-negative or solid stool. In subjects with diarrhoea of more than 2 weeks duration and three stool samples negative for enteric pathogens, FTNF-alpha greater than 15 U/ml has a sensitivity of 88% and a specificity of 66% for the diagnosis of diarrhoea-related CMV enteritis. CONCLUSION: TNF-alpha production may have a role in the pathogenesis of bacterial, microsporidial and CMV-related diarrhoea in HIV-seropositive individuals. Thus, anti-TNF-alpha agents may have a therapeutic role in the management of these conditions. FTNF-alpha greater than 15 U/ml in apparently pathogen-negative diarrhoea may suggest endoscopic gastrointestinal biopsy to diagnose CMV enteritis.
Keywords: AIDS-Related Opportunistic Infections/*METABOLISM/PHYSIOPATHOLOGY Diarrhea/ETIOLOGY/*METABOLISM Feces Human HIV Infections/*COMPLICATIONS Prospective Studies Tumor Necrosis Factor/*ANALYSIS JOURNAL ARTICLE 970330
M9731500
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.